PODLOGAR SUSAN M
Known title: DirectorCIK: 0001709959
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
LivaNova Shares Rise on Barclays Overweight Rating. Barclays has begun coverage of LivaNova, giving it an overweight rating and a $105 price target. The stock is currently trading near the upper end of its 52‑week range and has been on a 60% three‑year run, which some analysts see as undervalued. Technical indicators show an RSI of 45 and a support level at $78.13, with a support reject signal that may signal a short‑term consolidation.
Transaction History
| TVGNW | ▲ Buy | Grant | 75,000 | $0 | 9/11/2026 | View on chart |
| TVGN | ▲ Buy | Grant | 40,000 | $0 | 7/10/2026 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 4,042 | $0 | 6/15/2026 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 486 | $39K | 6/15/2026 | View on chart |
| LIVN | ▲ Buy | Option Exercise | 2,355 | $0 | 12/15/2025 | View on chart |
| LIVN | ▼ Sell | Tax Withholding | 269 | $17K | 12/15/2025 | View on chart |
| TVGN | ▲ Buy | Grant | 240,000 | $0 | 12/23/2024 | View on chart |
| TVGN | ▲ Buy | Grant | 193,923 | — | 2/14/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Tevogen Regains Nasdaq Listing Compliance
Tevogen Inc. has regained compliance with Nasdaq Global Market continued listing requirements. This development addresses potential delisting risks associated with the company's stock status. The news provides regulatory clarity for the ticker, which has seen significant price volatility over the past year.
Tevogen Regains Nasdaq Listing Compliance. Tevogen Inc. has regained compliance with Nasdaq Global Market continued listing requirements. This development addresses potential delisting risks associated with the company's stock status. The news provides regulatory clarity for the ticker, which has seen significant price volatility over the past year.